近年来，随着创新药物的迅猛发展，肿瘤免疫治疗的疗效和安全性已经获得了临床医生和科研人员广泛的认可与接纳。肿瘤浸润淋巴细胞（tumor-infiltrating lymphocytes，TILs）是指浸润到肿瘤组织中的淋巴细胞，包括 T 细胞和 B ...

Discover a study where findings suggest that a preoperative radiation therapy boost can safely induce a short-term increase ...

Greater tumor-infiltrating lymphocyte density is associated with improved overall survival outcomes in patients with ...

Higher TIL levels predict better survival in early ERBB2-positive breast cancer, supporting treatment de-escalation for ...

Researchers identify mitochondrial transfer between cancer and immune cells as a crucial mechanism for immune evasion. The ...

SM Energy Co (SM) anticipates significant cash flow and production growth, while addressing operational hurdles and strategic ...

Dr. Daniel Olson is hoping it's the first step in a whole new way of treating cancers like the one that was threatening Alla ...

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings not to do so from her treating oncologists.

Concept: Deubiquitinase USP30 protects cancer cell-derived mitochondria from ROS-induced mitophagy in TILs. Impact: Inhibiting mitochondrial transfer may improve responses to immune checkpoint ...

博主自制简易自动嗑瓜子机，再也不用担心磕坏牙了！网友：这个项目我王多鱼投了！

Introduction: The adoptive cell transfer of tumor-infiltrating lymphocytes (TILs) has proven clinically beneficial in patients with non-small cell lung cancer refractory to checkpoint blockade ...

Background: Tumor-infiltrating lymphocytes (TILs) have demonstrated potential as prognostic biomarkers across various cancer types. However, their prognostic implications in non-small cell lung cancer ...